![]() |
|
|
|
|
1
3rd July 08:57
External User
Posts: 1
|
Interesting study:
http://www.ajcn.org/cgi/content/full...f108ef31aa5b16 Current trends in health promotion emphasize the importance of reducing dietary fat intake. However, as dietary fat is reduced, the dietary carbohydrate content typically rises and the desired reduction in plasma cholesterol concentrations is frequently accompanied by an elevation of plasma triacylglycerol. We review the phenomenon of carbohydrate-induced hypertriacylglycerolemia, the health effects of which are among the most controversial and important issues in public health nutrition today. We first focus on how seminal observations made in the late 1950s and early 1960s became the basis for subsequent important research questions and areas of scientific study. The second focus of this paper is on the current knowledge of biological mechanisms that contribute to carbohydrate-induced hypertriacylglycerolemia. The clinical rationale behind mechanistic studies is this: if carbohydrate-induced hypertriacylglycerolemia shares a metabolic basis with endogenous hypertriacylglycerolemia (that observed in subjects consuming high-fat diets), then a similar atherogenic risk may be more likely than if the underlying metabolic mechanisms differ. The third focus of the paper is on both the positive metabolic changes that occur when high-carbohydrate diets are consumed and the potentially negative health effects of such diets. The review concludes with a summary of some important research questions that remain to be addressed. These issues include the level of dietary carbohydrate that induces carbohydrate-induced hypertriacylglycerolemia, whether the phenomenon is transient or can be avoided, whether de novo lipogenesis contributes to the phenomenon, and what magnitude of triacylglycerol elevation represents an increase in disease risk. |
|
|
|
|
2
3rd July 08:57
External User
Posts: 1
|
"tcomeau" <tunderbar@hotmail.com> ha scritto nel messaggio
news:b550f406.0310241523.77ca6453@posting.google.c om... http://www.ajcn.org/cgi/content/full...dd2ac896d0e975 e1f108ef31aa5b16 Ciculation 106; 2530-2532 2002 Circulation 1995; 92, 194-204 Am J Cardiol. 1992 Feb 15;69(5):440-4. Diabetes Care. 1983 May-Jun;6(3):268-73. Diabetes Care. 1982 Jul-Aug;5(4):370-4. Diabetes Care 17(12):1-4,'94 New England Journal of Medicine 323:1921, 1990 Arch Int Med 1991, 151: 1389 Am J Med. 1985 Jan;78(1):23-7. Jounal Of American College Nutrition 2003; 41, 263-272 Journal of Cardiopulmonary Rehabilitation 12:194-201,'92 Preventive Cardiology 5 3) 110-118 2002Preventive Cardiology 2:159-163, 1999 Engl J Med. 2002 Feb 7;346(6):393-403 J Clin Nutr 1994May;59(5):980-4 Obes Res. 2002 Feb;10(2):78-82. Journal of American College Nutrition 2002 21: 268-274 American Journal of Cardiology 79:1112, 1997, 93 We review the phenomenon of |
|
|
3
3rd July 08:58
External User
Posts: 1
|
also:
http://www.lbl.gov/Science-Articles/...-patternb.html "an extreme low fat/high carbohydrate diet can, for some individuals, actually increase the risk of heart disease, says a scientist with the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab)." |
|
|
4
23rd July 14:11
External User
Posts: 1
|
On 24 Oct 2003 16:23:31 -0700, tunderbar@hotmail.com (tcomeau) posted:
So many uncertainties. What is the form of the carb intake? Perhaps the wholefood/refined dichotomy is more important than the fat/carb dichotomy. What is the exercise regime of the subjects? What is the calorie balance and weight status of the subjects? In other words, it is likely heathiest to eat a high-carb, wholefood, eucaloric diet with regular moderate exercise. Any deviations from this will give a slight to moderate downside, that may also bring a benefit that tips it to be of net benefit.. Such things as eating higher-fat, eucaloric diets in some folk may give hunger-reducing benefits that outweigh the small disadvantages of the higher fat consumption. |
|
|
5
23rd July 14:11
External User
Posts: 1
|
On 25 Oct 2003 10:48:12 -0700, tunderbar@hotmail.com (tcomeau) posted:
The first half dozen words are: "Because of certain inherited genetic traits...." You *are* grasping at straw dust now. |
|
|
6
23rd July 14:13
External User
Posts: 1
|
It goes on to say:
"reported on the recent findings of his research group in which it was shown that in genetically susceptible individuals, an extreme low-fat/high-carbohydrate diet can produce metabolic reactions that cause a change in the cholesterol profile of their blood. Further along: "Tests for these genetically susceptible traits are not widely available." Note the words "in genetically susceptible individuals" What this says, in some set of people that can not be quantified have reacted in a certain manner. So, is two or 12 people as someone posted last week? Now your being the good propagandist and would like to generalize this across the entire population. Piss poor strawman. You are grasping at smoke to prove your case. -- Doug Freese "Caveat Lector" dfreeseS@NOBShvc.rr.com |
|
|
7
23rd July 14:13
External User
Posts: 1
|
x-no-archive: yes
In article <mAVmb.46305$pT1.11510@twister.nyc.rr.com>, Doug Freese <dfreese@NOBShvc.rr.com> writes: Reaven of Stanford Univ., and others estimate the prevalence of insulin resistance at 25 - 30% of the population. Further, research indicates that risk of CVD rises all along the spectrum of normal glucose levels and HbA1c, so it's logical to assume that the entire population would benefit from a lifestyle/diet that would lower these. Low carbing is the only diet to lower HbA1c and blood glucose levels. Ann Intern Med 1998 Apr 1;128(7):524-33 Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Meigs JB, Nathan DM, Wilson PW, Cupples LA, Singer DE Massachusetts General Hospital, Harvard Medical School, Boston University School of Public Health, 02114, USA. jmeigs@sol.mgh.harvard.edu BACKGROUND: Categorical definitions for glucose intolerance imply that risk thresholds exist, but metabolic risk for type 2 diabetes mellitus or cardiovascular disease may increase continuously as glucose intolerance increases. OBJECTIVE: To examine the distributions of the following metabolic risk factors across the spectrum of glucose tolerance: overall and central obesity, hypertension, low levels of high-density lipoprotein cholesterol, and increased triglyceride and insulin levels. DESIGN: Cross-sectional analysis. SETTING: The community-based Framingham Offspring Study. PARTICIPANTS: 2583 adults without previously diagnosed diabetes. MEASUREMENTS: Clinical data; fasting glucose, insulin, and lipid levels; and glucose and insulin levels taken 2 hours after oral challenge were collected from 1991 to 1993. Glucose tolerance was determined by 1980 World Health Organization criteria. Patients with normal glucose tolerance were categorized into quintiles of fasting glucose. The distributions of each metabolic risk factor and the metabolic sum of the six risk factors were assessed across seven categories from the lowest quintile of normal fasting glucose level through impaired glucose tolerance and previously undiagnosed diabetes. RESULTS: The mean age of patients was 54 years (range, 26 to 82 years); 52.7% of patients were women. Glucose tolerance testing found that 12.7% of patients had impaired glucose tolerance and 4.8% had previously undiagnosed diabetes. Multivariable-adjusted mean measures of risk factors and odds ratios for obesity, elevated waist-to-hip ratio, hypertension, low levels of high-density lipoprotein cholesterol, elevated triglyceride levels, and hyperinsulinemia showed continuous increases across the spectrum of nondiabetic glucose tolerance. Although a threshold effect near the upper range of nondiabetic glucose tolerance could not be ruled out for triglyceride levels in men and for insulin levels 2 hours after oral challenge in men and women, no other metabolic risk factors showed clear evidence of thresholds for increased risk. CONCLUSIONS: Metabolic risk factors for type 2 diabetes mellitus and for cardiovascular disease worsen continuously across the spectrum of glucose tolerance categories, beginning in the lowest quintiles of normal fasting glucose level. PMID: 9518396, UI: 98175274 Blood Glucose Concentration Linked to>Cardiovascular Risk in Nondiabetic Men> ---------------------------------------------------------------------------- WESTPORT,>CT (Reuters Health) Jan 04 - Increased glycated hemoglobin (HbA1c)>concentrations are predictive of cardiovascular mortality among all men,>not only those with diabetes, according to a report in the British>Medical Journal for January 6. Dr. Kay-Tee Khaw and colleagues, from>the University of Cambridge School of Clinical Medicine, UK, collected>data on all-cause mortality and cardiovascular mortality in 4662 men, 45>to 79 years of age, who participated in the Norfolk UK cohort of the>European Prospective Investigation into Cancer and Nutrition>(EPIC-Norfolk). At baseline, from 1995 to 1997, HbA1c was measured and>the subjects were followed until December 1999. As expected, Dr.>Khaw's group found that diabetic men had increased mortality for all>causes, cardiovascular disease and ischemic disease. They also noted that>HbA1c concentrations were "continuously related to subsequent all-cause,>cardiovascular, and ischemic mortality through the whole population." The>lowest mortality rates were associated with HbA1c concentrations below>5%. Further, the group noted that a 1% increase in HbA1c was>associated with a 28% increased risk of death, which was independent of>age, blood pressure, cholesterol, body mass index and>smoking. "Eighteen percent of the population excess mortality risk>associated with a HbA1c concentration of 5% or more occurred in men with>diabetes, but 82% occurred in men with concentrations of 5% to 6.9% (the>majority of the population)," Dr. Khaw and colleagues point>out. The researchers propose that an elevated concentrations of>HbA1c is a marker for greater absolute risk among all men, and>"preventive treatment with blood pressure- or cholesterol-lowering drugs>should be considered in such patients." They point out that if>the population of nondiabetic men was able to lower its HbA1c>concentration by 0.1%, total mortality could be reduced by 5%, and if the>concentration could be lowered by 0.2%, then total mortality could be>reduced by 10% in this population. -- Susan |
|
|
|